Trials / Completed
CompletedNCT01209351
Effect of Teduglutide on Gastric Emptying in Healthy Subjects
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dosing, Parallel Group Study to Assess the Effects of Teduglutide (ALX-0600) on Gastric Emptying in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to assess the effects of 10 consecutive, daily, subcutaneous doses of 4 mg of teduglutide as compared with placebo on gastric emptying as assessed by acetaminophen absorption kinetics in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | placebo |
| DRUG | teduglutide | teduglutide 4 mg |
Timeline
- Start date
- 2010-09-28
- Primary completion
- 2010-11-08
- Completion
- 2010-11-08
- First posted
- 2010-09-27
- Last updated
- 2021-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01209351. Inclusion in this directory is not an endorsement.